0001209191-23-026372.txt : 20230501 0001209191-23-026372.hdr.sgml : 20230501 20230501200017 ACCESSION NUMBER: 0001209191-23-026372 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230420 FILED AS OF DATE: 20230501 DATE AS OF CHANGE: 20230501 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kardes Hakan CENTRAL INDEX KEY: 0001975023 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40295 FILM NUMBER: 23876052 MAIL ADDRESS: STREET 1: C/O ALIGNMENT HEALTHCARE, INC. STREET 2: 1100 W. TOWN AND COUNTRY ROAD, SUITE 160 CITY: ORANGE STATE: CA ZIP: 92868 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alignment Healthcare, Inc. CENTRAL INDEX KEY: 0001832466 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 465596242 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 W. TOWN AND COUNTRY ROAD STREET 2: SUITE 1600 CITY: ORANGE STATE: CA ZIP: 92868 BUSINESS PHONE: 844-310-2247 MAIL ADDRESS: STREET 1: 1100 W. TOWN AND COUNTRY ROAD STREET 2: SUITE 1600 CITY: ORANGE STATE: CA ZIP: 92868 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2023-04-20 0 0001832466 Alignment Healthcare, Inc. ALHC 0001975023 Kardes Hakan 1100 W. TOWN & COUNTRY RD. SUITE 1600 ORANGE CA 92868 0 1 0 0 Chief Technology Officer Common Stock 317907 D Options (Right to Buy) 18.00 2031-03-25 Common Stock 69259 D Options (Right to Buy) 9.06 2032-03-08 Common Stock 36496 D Includes (i) 113,657 shares of Common Stock of Alignment Healthcare, Inc. (the "Company"); (ii) 20,566 shares of unvested restricted stock, all of which vest on July 15, 2023; (iii) 20,376 shares of unvested restricted stock, 50% of which vest on each of August 1, 2023 and August 1, 2024; (iv) 10,283 shares of unvested restricted stock, all of which vest on November 19, 2023; (v) 5,500 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company ("RSUs"), granted on March 25, 2021, 25% of which vested or will vest on each of the first four anniversaries of the grant date; (Cont.) (Cont. from footnote 1) (vi) 66,000 RSUs granted on April 9, 2021, 25% of which vested or will vest on each of the first four anniversaries of the grant date; (vii) 49,669 RSUs granted on March 8, 2022, 25% of which vested or will vest on each of the first four anniversaries of the grant date; and (viii) 44,482 RSUs granted on September 12, 2022, 50% of which will vest on or about each of the third and fourth anniversaries of the grant date. An aggregate of 12,626 shares have been sold upon vesting of RSUs in non-discretionary sale-to-cover transactions. In each case, vesting is subject to the reporting person's continued service to the Company as of the applicable vesting date. Options vested or will vest 25% on each of the first four anniversaries of the March 25, 2021 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Options vested or will vest 25% on each of the first four anniversaries of the March 8, 2022 grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. /s/ Richard A. Cross, as Attorney-in-Fact, for Hakan Kardes 2023-05-01 EX-24 2 poa.txt POA DOCUMENT POWER OF ATTORNEY KNOW ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints each of (i) R. Thomas Freeman, (ii) Richard A. Cross and (iii) Thomas E. Mitchell, signing SINGLY, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director or holder of 10% or more of the registered class of securities of Alignment Healthcare, Inc. (the "Company"), Forms 3, 4 and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4 or 5, complete and execute any amendment or amendments thereto and timely file such forms or amendments with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (3) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Exchange Act. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. * * * * * IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 24th day of April 2023. By: /s/ Hakan Kardes Name: Hakan Kardes